AnalystsLeland GershellLeland Gershell's Stock Forecasts
AnalystsLeland Gershell
Analyst Ranking
Top 4%
#177 out of 5080 analysts
Average Return
+26.39%
Win Rate
50%72 out of 143
Risk vs Reward
Poor
Good
Leland Gershell's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Soleno Therapeutics IncSLNO | +1,687.66% | $2.35 | $42.01 | 2023-03-23 - 2024-03-22 | Buy |
Soleno Therapeutics IncSLNO | +978.37% | $4.90 | $52.84 | 2023-09-14 - 2024-09-13 | Buy |
Soleno Therapeutics IncSLNO | +718.29% | $5.03 | $41.16 | 2023-05-24 - 2024-05-24 | Buy |
Urogen Pharma LtdURGN | +303.60% | $5.00 | $20.18 | 2025-06-02 - 2025-10-28 | Buy |
Crinetics Pharmaceuticals IncCRNX | +206.35% | $17.32 | $53.06 | 2023-08-30 - 2024-08-30 | Buy |
Leland Gershell Analyst Color
Get additional color on Leland Gershell's coverage of popular stocks
Leland Gershell's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viridian Therapeutics IncVRDN | 7 | Buy | $36.00 | +55.37% | Maintains | 8 days ago |
Crinetics Pharmaceuticals IncCRNX | 8 | Buy | $87.00 | +106.85% | Maintains | a month ago |
Tectonic Therapeutic IncTECX | 1 | Buy | $80.00 | +347.43% | Initiates Coverage On | 2 months ago |
Xeris Biopharma Holdings IncXERS | 3 | Buy | $8.00 | -13.33% | Maintains | 3 months ago |
Soleno Therapeutics IncSLNO | 9 | Buy | $110.00 | +60.21% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 2 | Buy | $61.00 | -5.43% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 5 | Buy | $490.00 | +2.96% | Upgrades | 3 months ago |
Lexeo Therapeutics IncLXEO | 1 | Buy | $20.00 | +98.41% | Initiates Coverage On | 3 months ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Buy | $110.00 | -3.05% | Maintains | 4 months ago |
Capricor Therapeutics IncCAPR | 5 | Buy | $22.00 | +255.99% | Maintains | 4 months ago |
Ascendis Pharma AASND | 10 | Buy | $224.00 | +8.79% | Maintains | 5 months ago |
Urogen Pharma LtdURGN | 10 | Buy | $31.00 | +53.62% | Maintains | 5 months ago |
Climb Bio IncCLYM | 1 | Buy | $10.00 | +380.77% | Initiates Coverage On | 5 months ago |
Argenx SeARGX | 7 | Buy | $708.00 | -15.35% | Maintains | 6 months ago |
Quince Therapeutics IncQNCX | 1 | Buy | $10.00 | +478.03% | Initiates Coverage On | 7 months ago |
Trevi Therapeutics IncTRVI | 3 | Buy | $20.00 | +89.93% | Maintains | 8 months ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $98.00 | +83.21% | Upgrades | 8 months ago |
Dianthus Therapeutics IncDNTH | 2 | Buy | $52.00 | +54.44% | Maintains | a year ago |
Ligand Pharmaceuticals IncLGND | 2 | Buy | $147.00 | -22.17% | Maintains | a year ago |
Veru IncVERU | 8 | Buy | $50.00 | +1,269.86% | Reiterates | a year ago |
Immunovant IncIMVT | 3 | Buy | $53.00 | N/A | Maintains | a year ago |
Engene Holdings IncENGN | 2 | Buy | $30.00 | N/A | Reiterates | a year ago |
Sab Biotherapeutics IncSABS | 2 | Buy | $12.00 | N/A | Reiterates | a year ago |
Nucana PLCNCNA | 8 | Buy | $5,000.00 | N/A | Maintains | a year ago |
Protara Therapeutics IncTARA | 3 | Buy | $25.00 | N/A | Maintains | a year ago |
Lumos Pharma IncLUMO | 5 | Buy | $13.00 | N/A | Maintains | a year ago |
Calcimedica IncCALC | 5 | Buy | $20.00 | N/A | Maintains | a year ago |
Catalyst Pharmaceuticals IncCPRX | 3 | Buy | $29.00 | N/A | Reiterates | a year ago |
Essa Pharma IncEPIX | 1 | Buy | $17.00 | N/A | Maintains | a year ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $35.00 | N/A | Upgrades | 2 years ago |
Cue Biopharma IncCUE | 1 | Buy | $10.00 | N/A | Maintains | 2 years ago |
Pds Biotechnology CorpPDSB | 3 | Buy | $20.00 | N/A | Maintains | 2 years ago |
Milestone Pharmaceuticals IncMIST | 3 | Buy | $13.00 | N/A | Maintains | 3 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Buy | $120.00 | N/A | Maintains | 3 years ago |
Clene IncCLNN | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Plx Pharma IncPLXPQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Buy | $140.00 | N/A | Initiates Coverage On | 4 years ago |
Grace Therapeutics IncGRCE | 3 | Buy | $36.00 | N/A | Initiates Coverage On | 4 years ago |
Opiant Pharmaceuticals IncOPNT | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 4 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 4 years ago |
Windtree Therapeutics IncWINT | 1 | Buy | $7,200.00 | N/A | Initiates Coverage On | 4 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Vaccinex IncVCNX | 2 | Buy | $1,470.00 | N/A | Maintains | 5 years ago |
Fresh Tracks Therapeutics IncFRTX | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 5 years ago |
Acceleron Pharma IncXLRN | 1 | Buy | $112.00 | N/A | Maintains | 6 years ago |
Epizyme IncEPZM | 1 | Hold | $16.00 | N/A | Downgrades | 6 years ago |
Amarin Corp PLCAMRN | 5 | Hold | N/A | N/A | Upgrades | 6 years ago |
Trevena IncTRVN | 1 | Buy | $8,125.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.